On 20 February 2003, the US Food and Drug Administration (FDA) published a new draft guidance relating to 21 CFR Part 11. The new guidance mainly affects the compliance requirements of systems with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback